The expected near-term clinical data is going to have limited effect on a company that is insolvent and at risk of running out of cash. 52 week low, so getting less cash per share an diluting the heck of current shareholders. Good luck!
Learning53- I think the price is going to bottom very soon, the core investors that are left will be very hard to shake. We understand the situation and the importance of the ongoing trials , once those results start to spill all that is wrong will be right. That’s why there is such a panic to keep us down, without those results the powers that be can continue it’s assault on every mistake a long the way. I don’t want another single announcement made unless it’s trial results .
Learning53- I think the price is going to bottom very soon, the core investors that are left will be very hard to shake. We understand the situation and the importance of the ongoing trials , once those results start to spill all that is wrong will be right. That’s why there is such a panic to keep us down, without those results the powers that be can continue it’s assault on every mistake a long the way. I don’t want another single announcement made unless it’s trial results .
Market Data 
Markets 
AI
